Search - tctmd.com

Displaying 761 - 780 of 790

Sort: Relevancy | Date

Presentation TCT 2012

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

Presenter: Samir Kapadia

October 24, 2012

Presentation TCT 2012

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Presenter: Ajay Kirtane

October 22, 2012

Presentation TCT 2012

Case Selection Caveats from the U.S. CoreValve Pivotal Clinical Trial

Presenter: Jeffrey Popma

October 22, 2012

News Industry News

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

October 19, 2012

News Daily News

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

L.A. McKeown

October 18, 2012

News Conference News ESC 2012

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Caitlin E. Cox

August 28, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

News Daily News

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

August 24, 2012

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Daily News

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

August 02, 2012

News Daily News

Registry Shows Better Survival for Women vs. Men After TAVR

Caitlin E. Cox

July 19, 2012

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Daily News

PARTNER A: La TAVR Transfemoral Mejora la CDV Precoz frente a la Cirugía

July 19, 2012

News Daily News

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

L.A. McKeown

July 18, 2012

News Daily News

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

Jason Kahn

June 18, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

CME

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

CME

Advertisement

PARTNER Cohort B Three Year: Clinical and Echocardiographic Outcomes from a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement in “Inoperable” Patients

The Influence of Gender on Clinical Outcomes in the PARTNER Trial

Case Selection Caveats from the U.S. CoreValve Pivotal Clinical Trial

FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Registries Show Strides for Transcatheter Valve Treatments in Europe

Cerebral Embolization During TAVR Comparable Across Access Routes, Devices

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

Registry Shows Better Survival for Women vs. Men After TAVR

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

PARTNER A: La TAVR Transfemoral Mejora la CDV Precoz frente a la Cirugía

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content